CVE-2026-39987 · Marimo Marimo · Published 2026-04-09
How bad would it be?
9.3 out of 10
CVSS rates it critical: about as damaging as flaws get.
How likely is it to be used?
over 99%
Estimated chance of exploitation in the next 30 days, among the top 1% of all scored flaws (EPSS, 2026-10-29).
Is it already being used?
Yes
CISA has seen it exploited in real attacks. For US government agencies the fix is deadline passed 176 days ago (2026-05-07).
What CISA says to do
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Marimo contains an pre-authorization remote code execution vulnerability, allowing an unauthenticated attacked to shell access and execute arbitrary system commands.
marimo is a reactive Python notebook. Prior to 0.23.0, Marimo has a Pre-Auth RCE vulnerability. The terminal WebSocket endpoint /terminal/ws lacks authentication validation, allowing an unauthenticated attacker to obtain a full PTY shell and execute arbitrary system commands. Unlike other WebSocket endpoints (e.g., /ws) that correctly call validate_auth() for authentication, the /terminal/ws endpoint only checks the running mode and platform support before accepting connections, completely skipping authentication verification. This vulnerability is fixed in 0.23.0.
Understand the kind of weakness behind this flaw. These resources teach the weakness, rather than reproduce this specific CVE. Follow the vendor's advice above to fix the affected product.
Missing authentication
A sensitive function is reachable without proving who is using it.
CWE is a catalogue of weakness types. Labels come from the sources shown and can differ or change. Resource matches reviewed 16 October 2026.
On SentryFeed
No story in the last 14 days has mentioned it.
Exploited flaws from CISA's KEV catalogue. Chance of exploitation from EPSS by FIRST. Descriptions and scores from the NVD. This product uses the NVD API but is not endorsed or certified by the NVD.